TickerFactsScreenerDevelopers

LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$936.4K2011: -$1.36M2012: -$1.21M2013: -$1.18M2014: -$1.64M2015: -$2.18M2016: -$1.68M2017: -$1.41M2018: -$1.51M2019: $1.67M2020: -$2.13M2021: -$4.14M2022: -$4.61M2023: -$4.29M2024: -$3.16M2025: -$3.07M-$3.07M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$3.07M+3.0%
2024-$3.16M+26.3%
2023-$4.29M+6.9%
2022-$4.61M-11.3%
2021-$4.14M-94.4%
2020-$2.13M-227.3%
2019$1.67M+210.8%
2018-$1.51M-7.0%
2017-$1.41M+15.8%
2016-$1.68M+23.1%
2015-$2.18M-33.4%
2014-$1.64M-38.6%
2013-$1.18M+2.1%
2012-$1.21M+11.3%
2011-$1.36M-45.2%
2010-$936.4K—